1 / 16

Payments to Research Subjects

Payments to Research Subjects. Margaret Byrne Department of Epidemiology and Public Health. Summary of talk. Why are incentives used? Do they work? Ethical concerns with use of incentives Practical concerns with incentives. Why are incentives used?.

eagan
Download Presentation

Payments to Research Subjects

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Payments to Research Subjects Margaret Byrne Department of Epidemiology and Public Health

  2. Summary of talk • Why are incentives used? Do they work? • Ethical concerns with use of incentives • Practical concerns with incentives

  3. Why are incentives used? - individuals believe their time/effort should be compensated for - individuals give up work or leisure time to participate - procedures might be onerous or unpleasant - need compensation to be able to participate

  4. Do incentives work? • Yes! • Pre- and post natal medical care • Smoking cessation interventions • Clinical trials • Drug treatment trials/interventions • 57-90% cite incentives as the motivating factor to participate

  5. Ethical issues surrounding incentives • Positive arguments • Negative arguments

  6. Positive arguments • Effectiveness at recruitment – saves time and money on research • Helps with retention • Recruits a more generalizable sample • Reduces therapeutic misconception

  7. Negative arguments • Financial incentives are coercive • Payments should not be used because they will influence people to participate – even if not coercive

  8. Financial incentives are coercive • Coercion necessarily involves a threat • Incentives for participating are an offer, not a threat • Unduly influential?

  9. Other ethical debates • Individuals sign on to too risky studies • Undue research burden on the poor • Individuals lie about eligibility • Payment “cheapen” goals and integrity of research • Patients in clinical trials already benefit

  10. Risk of trials • Payments may “blind” participants to the risk of the trials • People are often paid for more to take on risk

  11. Undue burden on poor • Not offering financial incentives to poor when we would offer to wealthier is paternalistic • Denying individual’s choice/chance to improve situation • Research shows wealthier are more influenced by the money

  12. Lie about eligibility • Possibly true • Screening procedures should resolve problem – not banning payments

  13. Payments “cheapen” research

  14. Patients versus healthy subjects • Argument that being in trial “offers people desirable therapeutic benefits” so shouldn’t need to pay • Research should only be done under conditions of equipoise • Argument reinforces the therapeutic misconception

  15. Practical issues of using financial incentives • How large should the payment be? • Balance of • Enough to be effective • Not too large so that we are wasting money • Very little research on this

  16. Practical issues of using financial incentives • Although not coercive per se, need to take people’s perceptions and situations into account • Too high/ pressure from family • Too low, we may be exploiting participants

More Related